235 related articles for article (PubMed ID: 17381371)
41. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
[TBL] [Abstract][Full Text] [Related]
42. Translating evidence into practice: use of statins in real-world patients with heart failure.
Hernandez AF; Fonarow GC
Heart Fail Clin; 2008 Apr; 4(2):217-23. PubMed ID: 18433702
[TBL] [Abstract][Full Text] [Related]
43. Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.
Gallegos PJ; Maclaughlin EJ; Haase KK
Pharmacotherapy; 2008 Mar; 28(3):343-55. PubMed ID: 18294114
[TBL] [Abstract][Full Text] [Related]
44. The pharmacist's role in the nonsteroidal anti-inflammatory drug selection process.
Barkin RL
Am J Ther; 2008; 15 Suppl 10():S17-9. PubMed ID: 19127124
[TBL] [Abstract][Full Text] [Related]
45. Implementing critical pathways and a multidisciplinary team approach to cardiovascular disease management.
Peterson ED; Albert NM; Amin A; Patterson JH; Fonarow GC
Am J Cardiol; 2008 Sep; 102(5A):47G-56G. PubMed ID: 18722192
[TBL] [Abstract][Full Text] [Related]
46. START (screening tool to alert doctors to the right treatment)--an evidence-based screening tool to detect prescribing omissions in elderly patients.
Barry PJ; Gallagher P; Ryan C; O'mahony D
Age Ageing; 2007 Nov; 36(6):632-8. PubMed ID: 17881418
[TBL] [Abstract][Full Text] [Related]
47. Contemporary approaches for evidence-based pharmacotherapy.
Gim S; Vincent WR
J Pharm Pract; 2013 Apr; 26(2):95-102. PubMed ID: 23459286
[TBL] [Abstract][Full Text] [Related]
48. The role of nurses in managing patients with heart failure.
Shotter C
Nurs Times; 2005 Mar 1-7; 101(9):36-7. PubMed ID: 15783158
[TBL] [Abstract][Full Text] [Related]
49. Cardiac resynchronisation therapy: evidence based benefits and patient selection.
Albouaini K; Egred M; Rao A; Alahmar A; Wright DJ
Eur J Intern Med; 2008 May; 19(3):165-72. PubMed ID: 18395159
[TBL] [Abstract][Full Text] [Related]
50. Guideline implementation research: exploring the gap between evidence and practice in the CRUSADE Quality Improvement Initiative.
Blomkalns AL; Roe MT; Peterson ED; Ohman EM; Fraulo ES; Gibler WB
Acad Emerg Med; 2007 Nov; 14(11):949-54. PubMed ID: 17967956
[TBL] [Abstract][Full Text] [Related]
51. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
Circ Heart Fail; 2008 Jul; 1(2):98-106. PubMed ID: 19808279
[TBL] [Abstract][Full Text] [Related]
52. The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design.
Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
Am Heart J; 2007 Apr; 153(4):478-84. PubMed ID: 17383282
[TBL] [Abstract][Full Text] [Related]
53. The impact of patient-specific quality-of-care report cards on guideline adherence in heart failure.
Matthews JC; Johnson ML; Koelling TM
Am Heart J; 2007 Dec; 154(6):1174-83. PubMed ID: 18035092
[TBL] [Abstract][Full Text] [Related]
54. [How to implement a guideline from theory to practice: the example of the venous thromboembolism prophylaxis].
Paiva EF; Rocha AT
Acta Med Port; 2009; 22(1):21-32. PubMed ID: 19341590
[TBL] [Abstract][Full Text] [Related]
55. Evidence-based medicine and patient choice: the case of heart failure care.
Sanders T; Harrison S; Checkland K
J Health Serv Res Policy; 2008 Apr; 13(2):103-8. PubMed ID: 18416916
[TBL] [Abstract][Full Text] [Related]
56. Care ideologies reflected in 4 conceptions of pharmaceutical care.
Björkman IK; Bernsten CB; Sanner MA
Res Social Adm Pharm; 2008 Dec; 4(4):332-42. PubMed ID: 19064240
[TBL] [Abstract][Full Text] [Related]
57. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
[TBL] [Abstract][Full Text] [Related]
58. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
59. Evidence-based emergency medicine. Creating a system to facilitate translation of evidence into standardized clinical practice: a preliminary report.
Wright SW; Trott A; Lindsell CJ; Smith C; Gibler WB
Ann Emerg Med; 2008 Jan; 51(1):80-6, 86.e1-8. PubMed ID: 17719134
[TBL] [Abstract][Full Text] [Related]
60. Switching to evidence-based once-daily beta-blockers for improved adherence to medication across the continuum of post-myocardial infarction left ventricular dysfunction and heart failure.
Abraham WT
Congest Heart Fail; 2008; 14(5):272-80. PubMed ID: 18983291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
